603716 Thalys Medical Technology Group Corporation.
- 6.07
- -0.09-1.46%
Thalys Medical Technology Group Corporation. News
Announcement on Additional Pledging of Shares by Controlling Shareholders
Announcement Regarding the Company's First Stock Repurchase through Centralized Competitive Trading Method.
Announcement on the progress of repurchasing and cancelling shares.
Report on Repurchasing Shares by means of Centralized Bidding Trading
Announcement on the pledge of some of the shares of the controlling shareholder
Announcement on the implementation results of the share repurchase and changes in shares
Notice explaining the situation of some repurchased shares that have not yet been cancelled when they have expired
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on cancellation of pledges and share pledges of some of the controlling shareholders' shares
Progress announcement on the transfer of shares in some holding subsidiaries and cancellation of subsidiaries
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Announcement on the supplementary pledge of some of the shares of the controlling shareholder
Announcement on the repurchase of the company\'s shares reaching 1% through centralized bidding transactions and the progress of the repurchase
Announcement on the first repurchase of company shares through centralized bidding
Repurchase report on the repurchase of company shares through centralized bidding transactions
Implementation Notice on Equity Incentives Restricted Stock Repurchase and Cancellation
Announcement on the cancellation of pledges and share pledges of some shares of the actual controller
Notice on cancellation of the pledge of shareholders\' shares
Announcement on the lifting of sales restrictions in the fourth phase of the 2019 Restricted Stock Incentive Plan and the unfulfilled sales restrictions and the repurchase and cancellation of restricted shares
Analysis
Price Target
No Data
